Eli Lilly and WuXi AppTec scored exits from the immunotherapy developer, which has seen its shares rocket 66% since it floated.

The Novo, Pfizer and Nan Fung-backed oncology therapy developer priced an upsized offering above its range and is now valued above $1bn.

Alphabet and Ping An are in line for exits after the online health insurer filed to float on the New York Stock Exchange.

Stanford spinout Bolt Biotherapeutics has raised more than twice as much as originally planned in an offering that also provided exits for corporates Pfizer, Novo and Fan Fung.

LendingTree-backed finance and investment platform operator Stash’s latest round took its total funding to $417m and valued it at $1.4bn.

Merck & Co and UnitedHealth Group are set to exit the urologic cancer diagnostics technology provider in an acquisition by Veracyte.

The Cambrian Biopharma-backed cancer treatment developer floated above its range in an offering on the Nasdaq Global Market.

Intact Ventures led an $11.5m round for the business insurance software provider that was also backed by Lackawanna Insurance Group.

Young Sohn is retiring while Luc Julia is leaving as Sean Kae and David Lee step up and into Samsung Catalyst and Samsung Next respectively.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.